CellVoyant

CellVoyant is an AI-first company developing closed-loop optimisation platforms for cell and tissue manufacturing based on their three products - FateView, FateCast, and FateSim. The products allow for label free (i.e., no need for genetic mutation or cell staining) identification, assessment, selection, prediction, and control of cell state and fate (i.e., future differentiation). The company so far has focused on induced Pluripotent Stem Cells (iPSCs). However, their end-to-end deep learning platform allows for generalisation across any cell types. The tech stack is composed of label free imaging and computer vision for cell identification with the key part of their techstack being the Bayesian Neural Networks that allow for time series analysis and quantification of all the physical and biological (e.g., growth factors) to steer the cells to a certain direction of interest. In other words, combining all three products, CellVoyant wants to develop autonomous driving of cell manufacturing.
CellVoyant colour logo
Founders / Management Rafael Carazo Salas
Sectors Biotechnology, Cell and Gene Therapy
Located in Bristol, UK
Co-Investors Octopus Ventures, Air Street Capital, Horizons Ventures
Follow On

LinkedIn

 

Sign up to receive our weekly newsletter and learn about investing in technologies that are changing the world.